A meta-analysis of fibromyalgia treatment interventions

Annals of Behavioral Medicine

Volumn 21, Issue 2, 1999, Pages 180-191

  Rossy, Lynn A ^a   Buckelew, Susan P ^a   Dorr, Nancy ^b   Hagglund, Kristofer J ^a   Thayer, Julian F ^a   McIntosh, Matthew J ^a   Hewett, John E ^a   Johnson, Jane C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CAPSAICIN; CARISOPRODOL; CHLORMEZANONE; CITALOPRAM; CYCLOBENZAPRINE; DOSULEPIN; FLUOXETINE; IBUPROFEN; MUSCLE RELAXANT AGENT; NAPROXEN; PREDNISONE; S ADENOSYLMETHIONINE; ZOLPIDEM;

ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; EXERCISE; FIBROMYALGIA; FUNCTIONAL ASSESSMENT; HUMAN; META ANALYSIS; SELF REPORT; TREATMENT PLANNING;

EID: 0032877246     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02908299     Document Type: Article

References (96)

1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism. 1995, 38(1):19-28.
2. White KP, Harth M: An analytical review of 24 controlled clinical trials for fibromyalgia syndrome (FMS). Pain. 1996, 64:211-221.
3. Baumstark KE, Buckelew SP: Fibromyalgia: Clinical signs, research findings, treatment implications, and future directions. Annals of Behavioral Medicine. 1992, 14(4):282-291.
4. Boissevain MD, McCain GA: Toward an integrated understanding of fibromyalgia syndrome. I. Medical and pathophysiological aspects. Pain. 1991, 45:227-238.
5. Boissevain MD, McCain GA: Toward an integrated understanding of fibromyalgia syndrome. II. Psychological and phenomenological aspects. Pain. 1991, 45:239-248.
6. Burckhardt CS, Bjelle A: Education programmes for fibromyalgia patients: Description and evaluation. Bailliere's. 1994, 8:935-954.
7. Gabriel SE, Bombardier C: Clinical trials in fibrositis: A critical review and future directions. Journal of Rheumatology. 1989, 16(Suppl. 19):177-179.
8. Godfrey RG: A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Archives of Internal Medicine. 1996, 156:1047-1052.
9. Goldenberg DL: A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome. Journal of Rheumatology. 1989, 16(Suppl. 19):137-139.
10. Harvey CK, Cadena R, Dunlap L: Fibromyalgia: Part 1. Review of the literature. Journal of the American Podiatric Medical Association. 1993, 7:412-415.
11. McCain GA: Role of physical fitness training in the fibrositis/ fibromyalgia syndrome. American Journal of Medicine. 1986, 81(3A): 73-77.
12. Reiffenberger DH, Amundson LH: Fibromyalgia syndrome: A review. American Family Physician. 1996, 53(5):1698-1704.
13. Yunus MB: Diagnosis, etiology, and management of fibromyalgia syndrome: An update [Review]. Comprehensive Therapy. 1988, 14(4):8-20.
14. Batra A, Bromer-Breitenbucher A, Kotier I, Dengler W, Bartels M: Psychometric variables before and after behavioral therapy in fibromyalgia. Journal of Musculoskeletal Pain. 1995, 3:47.
15. de Voogd JN, Knipping AA, de Blecourt ACE, van Rijswijk MH: Treatment of fibromyalgia syndrome with psycho-motor therapy and marital counselling [abstract]. Scandinavian Journal of Rheumatology. 1992, 94(Suppl.):49.
16. Gronblad M, Nykanen J, Konttinen Y, Jarvinen E, Helve T: Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. Clinical Rheumatology. 1993, 12:186-191.
17. Hannonen P, Rahkila P, Kallinen M, Alen M: Effects of prolonged aerobic vs. muscle strength training programs on fibromyalgia [abstract]. Journal of Musculoskeletal Pain. 1995, 3:34.
18. Hench PK, Cohen R, Mitler MM: Fibromyalgia: Effects of amitriptyline, temazepam and placebo on pain and sleep [abstract]. Arthritis and Rheumatism. 1989, 32(Suppl.):S47.
19. Hoydalsmo O, Johannsen I, Harstad H, Jacobsen S, Kryger P: Effects of a multidisciplinary training programme in fibromyalgia [abstract]. Scandinavian Journal of Rheumatology. 1992, 94(Suppl.):51.
20. Isomeri R, Mikkelsson M, Latikka P, Kammonen K: Effects of amitriptyline and cardiovascular fitness training on pain in patients with primary fibromyalgia. Journal of Musculoskeletal Pain. 1993, 1:253-260.
21. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B: Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials. Journal of Rheumatology. 1991, 18(3): 447-451.
22. Hannonen P, Rahkila P, Kallinen MO, Alen M: Reduction in pain perception in fibromyalgia during one-year strength and endurance training [abstract]. Journal of Musculoskeletal Pain. 1995, 3:162.
23. Kaplan KH, Goldenberg DL, Galvin-Nadeau M: The impact of a meditation-based stress reduction program on fibromyalgia. General Hospital Psychiatry. 1993, 15:284-289.
24. Kaziyama HHS, Miyazaki M, Imamura M, et al: Fibromyalgia: Continuous physical therapy program with or without long-term medical supervision [abstract]. Journal of Musculoskeletal Pain. 1995, 3:126.
25. Kleijnen J, Gerards FM, Kok G: Self management and the treatment of fibromyalgia: A randomized controlled trial [abstract]. Arthritis Care and Research. 1992, 5:S18.
26. Kogstad O, Hintringer F, Jonsson YM: Patients with fibromyalgia in pain schools [abstract]. Scandinavian Journal of Rheumatology. 1992, 94(Suppl.):48.
27. Maccabruni F, Ghirardini M, Betelemme L, Fatti F: Treatment of primary fibromyalgia with peridural sacral therapy [abstract]. Scandinavian Journal of Rheumatology. 1992, 94(Suppl.):57.
28. Nielson WR, Harth M, Bell DA: Outpatient cognitive-behavioural treatment of fibromyalgia: Impact on pain response and health status [abstract]. Journal of Musculoskeletal Pain. 1995, 3:122.
29. Norregaard J, Lykkegard J, Mehlsen J, Danneskiold-Samsoe B: Exercise training in treatment of fibromyalgia [abstract]. Journal of Musculoskeletal Pain. 1995, 3:105.
30. Pankoff B, Nielson WR: A general conditioning program for patients with fibromyalgia and its impact on function [abstract]. Journal of Musculoskeletal Pain. 1995, 3:156.
31. Pestelli G, Rossi RM, Serra A, Maltoni P, Zoli A: Fibromyalgia: What the best for? [abstract]. Scandinavian Journal of Rheumatology. 1992, 94(Suppl.):40.
32. Stratz T, Schochat T, Hrycaj P, et al: The blockade of 5-HT-3 receptors in fibromyalgia - A new therapy concept? [abstract]. Journal of Musculoskeletal Pain. 1995, 3:64.
33. Weverman I: A functional approach to the treatment of fibromyalgia in a physical therapy and stress management setting [abstract]. Journal of Musculoskeletal Pain. 1995, 3:31.
34. Wigers SH, Stiles TC, Vogel PA: Positive effects of aerobic exercise in fibromyalgia. A 4-year follow-up study [abstract]. Journal of Musculoskeletal Pain. 1995, 3:154.
35. Wysenbeek AJ, Mor F, Lurie Y, Weinberger A: Imipramine for the treatment of fibrositis: A therapeutic trial. Annals of the Rheumatic Diseases. 1985, 44:752-753.
36. Zizzo A, Zanelli R, Ercolani M, Chattat R: An experience of group psychotherapy body-oriented in fibromyalgic syndrome [abstract]. Scandinavian Journal of Rheumatology. 1992, 94(Suppl.):57.
37. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis and Rheumatism. 1990, 33(2):160-172.
38. Hedges LV: Distribution theory for Glass's estimator of effect size and related estimators. Journal of Educational Statistics. 1981, 6:107-128.
39. Hedges LV, Olkin I: Statistical Methods for Meta-Analysis. New York: Academic Press, 1985.
40. Johnson BT: DSTAT: Software for the Meta-Analytic Review of Research Literatures. Hillsdale, NJ: Lawrence Erlbaum Associates, 1989.
41. Handbook of Mathematical Functions. Washington, DC: National Bureau of Standards, 1964.
42. Rosenthal R: Parametric measures of effect size. In Cooper HM, Hedges LV (eds). The Handbook of Research Synthesis. New York: Russell Sage Foundation, 1994.
43. Glass GV, McGaw B, Smith ML: Meta-Analysis in Social Research. Newbury Park, CA: Sage Publications, Inc., 1981.
44. Cooper H, Nye B, Charlton K, Lindsay J, Greathouse S: The effects of summer vacation on achievement test scores: A narrative and meta-analytic review. Review of Educational Research. 1996, 66:227-268.
45. Shadish WR, Haddock CK: Combining estimates of effect size. In Cooper HM, Hedges LV (eds), The Handbook of Research Synthesis. New York: Russell Sage Foundation, 1994.
46. Cooper HM: Integrating Research: A Guide for Literature Reviews (2nd Ed.). Newbury Park, CA: SAGE Publications, Inc., 1989.
47. Di Benedetto P, Iona LG, Zidarich V: Clinical evaluation of s-adenosyl-1-methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research. 1993, 53(2):222-229.
48. Santandrea S, Montrone F, Sarzi-Puttiniti P, Boccassini L, Caruso I: A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. Journal of International Medical Research. 1993, 21:74-80.
49. Tavoni A, Vitali C, Bombardieri S, Pasero G: Evaluation of S-adenosylmethionine in primary fibromyalgia. American Journal of Medicine. 1987, 83(5A):107-110.
50. Grassetto M, Varotto Z: Primary fibromylagia is responsive to s-adenosyl-1-methionine. Current Therapeutic Research. 1994, 55(7): 797-806.
51. Ianniello A, Ostuni PA, Sfriso P, et al: S-adenosyl-1-methionine in Sjogren's Syndrome and fibromyalgia. Current Therapeutic Research. 1994, 55(6):699-706.
52. Jacobsen S, Danneskiold-Samsoe B, Andersen RB: Oral s-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation. Scandinavian Journal of Rheumatology. 1991, 20:294-302.
53. Volkmann H, Norregaard J, Jacobsen S, et al: Double-blinded, placebo-controlled cross-over study of intravenous s-adenosyl-1-methionine in patients with fibromyalgia. Scandinavian Journal of Rheumatology. 1997, 26:206-211.
54. Caruso I, Puttini PS, Cazzola M, Azzolini V: Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. Journal of International Medical Research. 1990, 18:201-209.
55. Puttini PS, Caruso I: Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: A 90-day open study. Journal of International Medical Research. 1992, 20(2):182-189.
56. Fossaluzza V, De Vita S: Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. International Journal of Clinical Pharmacological Research. 1992, 12(2):99-102.
57. Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis and Rheumatism, 1986, 29(11):1371-1377.
58. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG: Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. Arthritis and Rheumatism. 1991, 34(5):552-560.
59. McCarty DJ, Csuka M, McCarthy G, Trotter D: Treatment of pain due to fibromyalgia with topical capsaicin: A pilot study. Seminars in Arthritis and Rheumatism. 1994, 23(6):41-47.
60. R. A randomized, double blind, placebo controlled, crossover pilot study. Journal of Rheumatology. 1995, 22(5):953-958.
61. Simms RW: Controlled trials of therapy in fibromyalgia syndrome. Bailliere's. 1994, 8(4):917-934.
62. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL: Electroacupuncture in fibromyalgia: Results of a controlled trial. British Medical Journal. 1992, 305:1249-1252.
63. Ferraccioli G, Ghirelli L, Scita F, et al: EMG-biofeedback training in fibromyalgia syndrome. Journal of Rheumatology. 1987, 14(4):820-825.
64. Buckelew SP, Conway R, Parker J, et al: Biofeedback/relaxation training and exercise interventions for fibromyalgia: A prospective trial. Arthritis Care and Research. 1998, 11:196-209.
65. Haanen HCM, Hoenderdos HTW, van Romunde LKJ, et al: Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. Journal of Rheumatology. 1991, 18(1):72-75.
66. McCain GA, Bell DA, Mai FM, Halliday PD: A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis and Rheumatism. 1988, 31(9):1135-1141.
67. Martin L, Nutting A, Macintosh BR, et al: An exercise program in the treatment of fibromyalgia. Journal of Rheumatology. 1996, 23(6):1050-1053.
68. Burckhardt CS, Mannerkorpi K, Hedenberb L, Bjelle A: A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. Journal of Rheumatology. 1994, 21:714-720.
69. Goldenberg DL, Kaplan KH, Nadeau MG, et al: A controlled study of a stress-reduction, cognitive-behavioral treatment program in fibromyalgia. Journal of Musculoskeletal Pain. 1994, 2(2):53-65.
70. Wigers SH, Stiles TC, Vogel PA: Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5-year follow-up study. Scandinavian Journal of Rheumatology. 1996, 25:77-86.
71. Nichols DS, Glenn TM: Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy. 1994, 74(4):327-332.
72. Mengshoel AM, Komnaes HB, Forre O: The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical and Experimental Rheumatology. 1992, 10:345-349.
73. Yunus MB, Masi AT, Aldag JC: Short-term effects of ibuprofen in primary fibromyalgia syndrome: A double blind, placebo controlled trial. Journal of Rheumatology. 1989, 16(4):527-532.
74. Nielson WR, Walker C, McCain GA: Cognitive-behavioral treatment of fibromyalgia syndrome: Preliminary findings. Journal of Rheumatology. 1992, 19(1):98-103.
75. Ostuni PA, Cassisi GA, Ianniello A, et al: Acupuncture vs. low-dose myanserine in primary fibromyalgia [abstract]. Journal of Musculoskeletal Pain. 1995, 3:88.
76. Carette S, Bell MJ, Reynolds WJ, et al: Comparison of amitriptyline. cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis and Rheumatism. 1994, 37:32-40.
77. Goldenberg DL, Mayskiy M, Mossey C, Ruthazer R, Schmid C: A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis and Rheumatism. 1996, 39(11):1852-1859.
78. Wolfe F, Cathey MA, Hawley DJ: A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scandinavian Journal of Rheumatology. 1994, 23:255-259.
79. Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis and Rheumatism. 1986, 29(5):655-659.
80. Pioro-Boisset M, Esdaile JM, Fitzcharles M: Alternative medicine use in fibromyalgia syndrome. Arthritis Care and Research. 1996, 9:13-17.
81. Nicassio PM, Schuman C, Kim J, Cordova A, Weisman MH: Psychosocial factors associated with complementary treatment use in fibromyalgia. Journal of Rheumatology. 1994, 24:2008-2013.
82. Eisenberg DM, Lessler RC, Foster C, et al: Unconventional medicine in the United States. New England Journal of Medicine. 1993, 325:246-252.
83. Bennett RM, Burckhardt CS, Clark SR, et al: Group treatment of fibromyalgia: A 6-month outpatient program. Journal of Rheumatology. 1996, 23(3):521-528.
84. Vlaeyen JWS, Teeken-Gruben NJG, Goossens MEJB, et al: Cognitive-educational treatment of fibromyalgia: A randomized clinical trial. I. Clinical effects. Journal of Rheumatology, 1996, 23:1237-1245.
85. White KP, Nielson WR: Cognitive-behavioral treatment of fibromyalgia syndrome: A follow-up assessment. Journal of Rheumatology. 1995, 22:717-721.
86. Mengshoel AM, Forseth KO, Haugen M, Walle-Hansen R, Forre O: Multidisciplinary approach to fibromyalgia: A pilot study. Clinical Rheumatology. 1995, 14(2):165-170.
87. Nicassio PM, Radojevic V, Weisman MH, et al: A comparison of behavioral and educational interventions for fibromyalgia. Journal of Rheumatology. 1997, 24:2000-2007.
88. Aaron LA, Bradley LA, Alarcon GS, et al: Psychiatric diagnosis in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis and Rheumatism. 1996, 39(3):436-445.
89. Ahles TA, Yunus MB, Riley SD, Bradley JM, Masi AT: Psychological factors associated with primary fibromyalgia syndrome. Arthritis and Rheumatism. 1984, 27(10):1101-1106.
90. Goldenberg DL: Psychologic studies in fibrositis. American Journal of Medicine. 1986, 81(3A):67-70.
91. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L: Comorbidity of fibromyalgia with medical and psychiatric disorders. American Journal of Medicine. 1992, 92:363-367.
92. Wolfe F, Cathey MA, Kleinheksel SM, et al: Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. Journal of Rheumatology. 1984, 11(4):500-506.
93. Potts MK, Silverman SL: The importance of aspects of treatment for fibromyalgia (fibrositis). Arthritis Care and Research. 1990, 3(1): 11-18.
94. Lipsey MW, Wilson DB: The efficacy of psychological, educational, and behavioral treatment: Confirmation from meta-analysis. American Psychologist. 1993, 48(12):1181-1209.
95. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Journal of the American College of Rheumatology. 1990, 33:1449-1461.
96. Blanchard EB, Andrasik F, Ahles TI, Teders SJ, O'Keefe D: Migraine and tension headache: A meta-analytic review. Behavior Therapy. 1980, 11:613-631.